Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

Sagemark Medical Imaging Centers All Receive ACR Accreditation

Posted on: Tuesday, 5 June 2007, 15:00 CDT

The Sagemark Companies Ltd. (OTCBB:SKCO), a national owner and operator of out-patient positron emission tomography (PET) and PET/CT medical diagnostic imaging centers, announced today that all of its imaging centers have received accreditation by the American College of Radiology ("ACR").

The ACR, headquartered in Reston, Virginia, awards accreditation to medical facilities for the achievement of high practice standards after a peer-review evaluation. Evaluations are conducted by board-certified physicians and medical physicists who are experts in the field. They access the qualification of the personnel and the adequacy of the facility equipment.

"We are delighted that each of our imaging centers has met the strict standards of the American College of Radiology," stated Michael Fagien, MD, Chief Medical Officer for The Sagemark Companies Ltd.

"Our imaging facilities are centers of medical excellence and 100% ACR accreditation is a testament to the excellent imaging service we provide to each and every patient," continued Dr. Fagien. "We are especially proud of the ACR accreditation on May 29th of Premier PET Imaging of Jacksonville for oncology and brain procedures, as well as for cardiac PET perfusion studies using ammonia N-13, to our knowledge, the only out-patient center in the United States to receive such an honor."

About The Sagemark Companies Ltd.

The Sagemark Companies Ltd. owns, operates and administers out-patient medical diagnostic imaging centers that utilize positron emission tomography (PET), and PET and computed tomography (PET/CT) equipment, an advanced diagnostic imaging procedure used by physicians in the detection and staging of certain cancers, coronary disease and neurological disorders. Additionally, the Company is planning to develop cancer treatment centers featuring the TomoTherapy® Hi-Art® treatment system developed by TomoTherapy Incorporated (NASDAQ: TTPY) one of the most advanced and versatile radiation therapy systems commercially available for the treatment of a wide variety of cancers.

Forward Looking Statements

This press release contains forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected.


Source: Business Wire

More News in this Category


Related Articles



Rating: 3.1 / 5 (9 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required